Donald Rauh, MD
Gastroenterology · Lexington, KYNPI 1548266976
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 562 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by AbbVie at 40.2% of the total. Reporting peaked in 2023 at $2,038 and has fallen 98.8% since, to $25 in 2025.
Across 562 payments — averaging $14.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Gilead$540
- Takeda Pharmaceuticals U.S.A., Inc.$532
- Johnson & Johnson$481
- Ironwood Pharmaceuticals, Inc$331
- plus $2K from 24 others
Across 2 payments — averaging $9649.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Intercept Pharma Europe Ltd.$19K
What the payments were for
- Food & beverage$8,15999%
- Education$511%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 248 | $3,302 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 89 | $1,202 |
| Gilead | 28 | $540 |
| Takeda Pharmaceuticals U.S.A., Inc. | 36 | $532 |
| Johnson & Johnson | 32 | $481 |
| Ironwood Pharmaceuticals, Inc | 24 | $331 |
| Intercept Pharmaceuticals, Inc. | 12 | $200 |
| Regeneron Healthcare Solutions, Inc. | 5 | $191 |
| Nestle Healthcare Nutrition Inc. | 10 | $188 |
| Bristol Myers Squibb | 11 | $170 |
| Pfizer | 9 | $148 |
| QOL Medical, LLC | 9 | $145 |
| Ferring Pharmaceuticals Inc. | 6 | $120 |
| Organon | 7 | $96 |
| UCB, Inc. | 6 | $87 |
| Merck | 6 | $86 |
| Daiichi Sankyo Inc. | 4 | $64 |
| AMAG Pharmaceuticals, Inc. | 3 | $51 |
| Sanofi | 2 | $38 |
| Alfasigma USA, Inc. | 2 | $34 |
| Ardelyx, Inc. | 2 | $33 |
| Shionogi Inc | 2 | $32 |
| Dynavax Technologies Corporation | 2 | $29 |
| Evoke Pharma, Inc. | 1 | $24 |
| AstraZeneca | 1 | $18 |
| Shire North American Group Inc | 1 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Masimo Corporation | 1 | $13 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$114
How this compares
$8,211 in reported general payments places this provider in the 75th percentile of 207 gastroenterology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mesalamine | 18 | $9,397 |
| Famotidine | 57 | $646 |
| Pantoprazole Sodium | 63 | $635 |
| Sucralfate | 16 | $401 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 22 | $286 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 21 | $222 |
| Omeprazole | 22 | $218 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Lexington
- Terrence BarrettLexington$57K
- An-Yu ChenLexington$25K
- Kathleen MartinLexington$23K
- Gregory WoolfolkLexington$19K
- Matthew AshmunLexington$19K
- Deborah FlomenhoftLexington$18K
- Scott MerkleyLexington$18K
- James PezziLexington$15K
- Adalberto CastellanosLexington$13K
- June YongLexington$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.